This topic contains a solution. Click here to go to the answer

Author Question: A woman is being treated for vulvovaginal candidiasis with butoconazole. The nurse will advise the ... (Read 46 times)

rmenurse

  • Hero Member
  • *****
  • Posts: 513
A woman is being treated for vulvovaginal candidiasis with butoconazole. The nurse will advise the patient to refrain from
 
  A) bathing while using the topical antifungal agent.
  B) sexual intercourse if she relies on condoms for contraception.
  C) drinking coffee while using the medication.
  D) eating fatty foods during the drug therapy.

Question 2

A patient is prescribed voriconazole (Vfend) for esophageal candidiasis. Which of the following adverse effects will the patient most likely experience?
 
  A) Visual disturbances
  B) Anorexia
  C) Abdominal pain
  D) Diarrhea



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mistyjohnson

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

B

Answer to Question 2

A



rmenurse

  • Hero Member
  • *****
  • Posts: 513
Both answers were spot on, thank you once again




 

Did you know?

The B-complex vitamins and vitamin C are not stored in the body and must be replaced each day.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library